News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current AGRX market cap is 1.51M. The company's latest EPS is USD -5.7591 and P/E is -0.07.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3M | 4M | 3.81M | 5.5M | 6.66M |
| Operating Income | -7.59M | -6.88M | -6.71M | -5.13M | -4M |
| Net Income | -19.66M | 18.24M | -5.39M | -3.81M | -798k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 749k | 4.1M | 10.88M | 19.59M |
| Operating Income | -18.86M | -49.05M | -71.01M | -41.43M | -19.88M |
| Net Income | -18.61M | -51.85M | -74.89M | -25.41M | -14.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 18.46M | 14.24M | 13.7M | 12.57M | 10.89M |
| Total Liabilities | 12.2M | 19.79M | 23.13M | 24.69M | 23.3M |
| Total Equity | 6.26M | -5.55M | -9.43M | -12.12M | -12.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 49.54M | 73.06M | 39.33M | 14.24M | 10.26M |
| Total Liabilities | 3.8M | 23.73M | 30.06M | 19.79M | 26.57M |
| Total Equity | 45.75M | 49.33M | 9.27M | -5.55M | -16.32M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -34.39M | -35.95M | -1.6M | -10.11M | -9.75M |
| Investing | -133k | -133k | N/A | N/A | N/A |
| Financing | 21.52M | 22.18M | 778k | 7.65M | 7.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.69M | -47.31M | -65.2M | -35.95M | -9.58M |
| Investing | -98k | -40.69M | 39.46M | -133k | N/A |
| Financing | 42.42M | 67.99M | 30.42M | 22.18M | 6.89M |
| Market Cap | 1.51M |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 0.05 |
| Price to Cash Ratio | 0.39 |
| Price to Book Ratio | -0.06 |
| Dividend Yield | - |
| Shares Outstanding | 2.51M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -90.97% |
| 52 Week High | 6.9999 |
| 52 Week Low | 0.504 |
| Spread (Intraday) | 0.03 (9.82%) |
| Company Name | Agile Therapeutics Inc |
| Address |
1111b s governors ave dover, delaware 19904 |
| Website | https://www.agiletherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
